Introduction

• Virologic cure is a realistic goal for most patients with HCV in settings where new direct-acting antivirals are available

The goal of antiviral therapy for patients with hepatitis C virus (HCV) is virologic cure. Eradication of HCV RNA, which remains undetectable long term off therapy, is referred to as a sustained virologic response and is now an achievable prospect for nearly all patients thanks to the availability of direct-acting antivirals (DAAs). Several classes of DAAs have been approved for the treatment of chronic HCV infection during the last 6 years, leading to dramatic shifts in the HCV landscape. This module focuses on evidence-based management approaches for patients with HCV infection, including treatment of patients with cirrhosis, strategies for drug resistance, and posttreatment management.

Goals of Therapy

• Goal of HCV therapy is virologic cure defined as SVR after HCV therapy is discontinued
• SVR associated with decreases in all-cause mortality, liver-related death, liver-related complications, need for liver transplantation, and incidence of hepatocellular cancer[Morgan 2010; ...

  Action required

  • Login now to access all of your entitled content
    or
  • View additional options to gain access to this content